Peptide Guides
Important
BPC-157 is not an approved medicine in any country. It holds no licence from the MHRA in the United Kingdom, the EMA in Europe, or the FDA in the United States. This guide explains anti-doping rules. It is not medical advice, and nothing within it constitutes a recommendation to use BPC-157. Products supplied through this site are intended for laboratory research use only.
Quick answer
- Yes. BPC-157 is banned in sport at all times, in and out of competition.
- It is named on the 2026 WADA Prohibited List as an example under S0 Non-Approved Substances, and S0 also operates as a class, so an unapproved substance can be prohibited even without being named.
- Anti-doping laboratories have published detection methods for BPC-157 in urine and blood.
- Athletes are strictly liable for prohibited substances found in their sample, whether use was intentional or accidental.
| Anti-doping status of BPC-157 | |
|---|---|
| Status checked | 16 September 2026 |
| List checked | WADA Prohibited List 2026, effective 1 January 2026 |
| Category | S0 Non-Approved Substances, named as an example |
| Prohibited | At all times, in and out of competition |
We review this page whenever WADA publishes a new Prohibited List.
Is BPC-157 banned in sport?
Yes. BPC-157 is banned for athletes at all times, in competition and out of it. The 2026 WADA Prohibited List names BPC-157 as an example under its S0 Non-Approved Substances category, the United States Anti-Doping Agency identifies it specifically as an S0 substance, and UK Anti-Doping applies the same list to athletes in the United Kingdom.1,2,3
An athlete in any tested sport should treat BPC-157 as a banned substance with no grey area. The rest of this guide explains the machinery behind that answer.
What WADA and the Prohibited List are
The World Anti-Doping Agency, WADA, is the body that sets the anti-doping rules used across international sport. Its Prohibited List is the document naming what athletes may not use, updated every year and taking effect each 1 January, and national agencies enforce it. In the United States that is USADA, and in the United Kingdom it is UK Anti-Doping, UKAD.
The list has two kinds of ban. Some substances are prohibited only in competition. Others are prohibited at all times, meaning an athlete may not use them in training months any more than on competition day. S0, the category that covers BPC-157, is an all-times category.
The S0 category and where BPC-157 sits
S0 is the list's first category. It prohibits any pharmacological substance that is not covered by a later section of the list and has no current approval from any governmental health authority for human therapeutic use. Unapproved compounds, discontinued drugs, and substances only ever tested in animals or laboratories all fall inside it.
BPC-157 is caught twice over. It fits the S0 definition, because no regulator anywhere has approved it as a medicine, which our full guide to BPC-157 covers in detail. And the 2026 list also names it directly, listing S0 examples as including but not limited to BPC-157.1 The compound has been specifically identified under S0 since the 2022 list, so its prohibited status is explicit rather than a matter of interpretation.
If BPC-157 were ever approved for human therapeutic use, its S0 status would need reassessing against the Prohibited List in force at that time. Approval by itself would not tell an athlete whether the substance had become permitted.
Can anti-doping tests detect BPC-157?
Yes. BPC-157 first drew anti-doping attention when it was identified in confiscated vials, and a validated urine detection method was published in 2017, sensitive to 0.1 nanograms per millilitre and covering a breakdown product of the compound as well as the compound itself.4
Detection capability has kept developing since. A published 2026 anti-doping workflow included BPC-157 among 54 prohibited compounds detectable in serum, plasma and dried blood spots.5 One published method does not establish what every laboratory runs routinely, and the direction is clear. The analytical tools to find BPC-157 exist, are validated, and are current.
Strict liability and contaminated products
For a presence violation, anti-doping operates on strict liability. The athlete is responsible for prohibited substances found in their sample, whether use was intentional or accidental, and proving intent is not required for the violation itself. The circumstances and degree of fault can still matter when the sanction is determined, which is why contamination cases are argued over consequences rather than over whether a violation occurred.
Research peptides carry contamination risk in a specific form, because no regulator checks what any research vial contains, and a vial can contain substances its label never mentions. A genuine, batch-specific certificate of analysis, the document our guide to certificates of analysis explains, can provide evidence about the sample that was tested. It cannot make a prohibited product permissible under anti-doping rules.
The UK anti-doping position
UK Anti-Doping enforces the WADA code and the WADA Prohibited List for UK athletes, so the S0 position applies unchanged in the United Kingdom.3 The prohibition applies out of competition as well as in it, and athletes within relevant testing programmes may be tested outside competition as well as at events.
Banned in sport versus illegal
Banned in sport and illegal are different systems with different consequences. In the UK, supplying BPC-157 for laboratory research is lawful, and possession is generally not an offence, which our guide to BPC-157's UK legal status sets out in full. None of that lawfulness helps an athlete, because anti-doping rules are contractual rules of sport that sit on top of the general law. A substance can be legal to possess and still lead to an anti-doping rule violation when it appears in a sample.
Checking a substance before competing
Athletes and support personnel should check the current WADA Prohibited List directly, use Global DRO to check the status of a specific substance or medication in their sport, and contact their national anti-doping organisation where anything is unclear. Those sources are the authorities on what is prohibited, and this page is reviewed against the current list rather than replacing it.
For transparency, we sell research peptides and we market nothing to athletes.
Common questions about BPC-157 in sport
Is BPC-157 banned by WADA?
Yes, at all times. The 2026 Prohibited List names BPC-157 as an example under the S0 Non-Approved Substances category, and it has been specifically identified there since the 2022 list.1,2
Why is BPC-157 banned in sport?
Because it is an unapproved pharmacological substance, and the S0 category prohibits all such substances as a class, with BPC-157 named among its examples. The ban does not depend on proof that the compound enhances performance or proof that it is harmful. Its unapproved status alone is sufficient.
Does BPC-157 show up on a drug test?
Sport anti-doping testing is the context where detection applies, and laboratories have published validated methods for BPC-157 in urine and blood.4,5 Routine workplace drug tests look for common recreational drugs and do not screen for research peptides. An athlete should assume a doping control sample can be tested for it.
How long is BPC-157 detectable?
No published human study defines a detection window, because the controlled human research that would measure one has never been done. What is published is capability, meaning validated methods sensitive to fractions of a nanogram, and an athlete should assume detection rather than attempt to estimate a window that no data defines.
References
- World Anti-Doping Agency. Prohibited List 2026, effective 1 January 2026, category S0: Non-Approved Substances. WADA
- US Anti-Doping Agency. BPC-157: experimental peptide creates risk for athletes, updated August 2026. USADA
- UK Anti-Doping. The Prohibited List and what is banned in sport. UKAD
- Cox HD, Miller GD, Eichner D. Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H. Drug Test Anal. 2017. DOI
- Mazzarino M, Colpaert T, Deventer K, Van Eenoo P. Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices. Analyst. 2026. DOI